More about Circassia
Circassia Pharmaceuticals Plc Ord 0.08P is listed on the London Stock Exchange trading with ticker code CIR.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £9,340m, with approximately 375m shares in issue. Over the last year, Circassia share price has been traded in a range of 39.65, hitting a high of 52.90, and a low of 13.25.
Circassia Pharmaceuticals Plc, officially known as Circassia Pharmaceuticals Plc Ord 0.08P was formed in May of 2006, making the company fourteen years old. The company filed its latest accounts on 31st December 2014. Circassia Pharmaceuticals Plc currently has 11 directors, and has had 4 previous directors over the last 14 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 8.50 million paid in salaries to the 49 staff (average wage of 173 thousand), with the directors receiving an average 392 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Circassia Pharmaceuticals Plc to have a net worth of 188.71 million, with 186.59 million held in cash.
Circassia is in the Medicine and Biotech Research sector.
 | Evraz (EVR.L) |  |
 | Fidelity China Special Situations Plc (FCSS.L) | |
 | Murray Inc.tst. (MUT.L) | |
 | St.modwen Properties (SMP.L) | |
 | Bank Of Georgia Group (BGEO.L) | |
 | Marstons (MARS.L) | |
| Evraz (EVR.L) | |
| Fidelity China Special Situations Plc (FCSS.L) | |
| Murray Inc.tst. (MUT.L) | |
 | 4d Pharma Plc (DDDD.L) | |
Circassia Share Information
| Volume | 9m |
|---|---|
| Currency | GBX |
| Shares in Issue | 375m |
| Market Capitalisation | £9,340m |
| 52 Week High | 52.90 |
| 52 Week Low | 13.25 |